Role of LFA‐1 in the activation and trafficking of T cells: Implications in the induction of chronic colitis

Introduction: We have previously demonstrated that adoptive transfer of naïve CD4+ T cells devoid of lymphocyte function‐associated antigen‐1‐deficient (LFA‐1; CD11a/CD18) into recombination activating gene‐1 (RAG‐1) deficient (RAG−/−) mice fails to induce chronic colitis whereas transfer of wild type (WT) T‐cells induces unrelenting and chronic disease. Methods: The objectives of this study were to assess the role of lymphocyte function‐associated antigen‐1 (LFA‐1) in enteric antigen (EAg)‐induced activation of T cells in vitro and in vivo and to define the importance of this integrin in promoting trafficking of T cells to the mesenteric lymph nodes (MLNs) and colon. Results: We found that EAg‐pulsed dendritic cells (DCs) induced proliferation of LFA‐1‐deficient (CD11a−/−) CD4+ T cells that was very similar to that induced using WT T cells, suggesting that LFA‐1 is not required for activation/proliferation of T cells in vitro. Coculture of WT or CD11a−/− T cells with EAg‐pulsed DCs induced the generation of similar amounts of interferon‐gamma, interleukin (IL)‐4, and IL‐10, whereas IL‐17A production was reduced ≈2‐fold in cocultures with CD11a−/− T cells. Short‐term (20–22 hours) trafficking studies demonstrated that while both WT and CD11a−/− T cells migrated equally well into the spleen, liver, lungs, small intestine, cecum, and colon, trafficking of CD11a−/− T cells to the MLNs was reduced by 50% when compared to WT T cells. When the observation period was extended to 3–7 days posttransfer, we observed ≈2–3‐fold more WT T cells within the MLNs and colon than CD11a−/− T cells, whereas T‐cell proliferation (as measured by CFSE dilution) was comparable in both populations. Conclusions: Taken together, our data suggest that LFA‐1 is not required for EAg‐induced activation of CD4+ T cells in vitro or in vivo but is required for trafficking of T cells to the MLNs and homing of colitogenic effector cells to the colon where they initiate chronic gut inflammation. (Inflamm Bowel Dis 2012;)

[1]  C. Loddenkemper,et al.  Regulatory T Cells in Patients with Whipple’s Disease , 2011, The Journal of Immunology.

[2]  M. Grisham,et al.  Pharmacological intervention studies using mouse models of the inflammatory bowel diseases: translating preclinical data into new drug therapies , 2011, Inflammatory bowel diseases.

[3]  D. Ostanin,et al.  Role of the gut‐associated and secondary lymphoid tissue in the induction of chronic colitis , 2011, Inflammatory bowel diseases.

[4]  C. Elson,et al.  Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis , 2010, The Journal of experimental medicine.

[5]  T. Hibi,et al.  Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. , 2009, Gastroenterology.

[6]  Richard A Flavell,et al.  A protective function for interleukin 17A in T cell–mediated intestinal inflammation , 2009, Nature Immunology.

[7]  D. Ostanin,et al.  T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[8]  C. Parish,et al.  Use of the Intracellular Fluorescent Dye CFSE to Monitor Lymphocyte Migration and Proliferation , 2009, Current protocols in immunology.

[9]  W. Agace T-cell recruitment to the intestinal mucosa. , 2008, Trends in immunology.

[10]  F. Powrie,et al.  Dendritic cells in intestinal immune regulation , 2008, Nature Reviews Immunology.

[11]  C. Smith,et al.  Developmental Control of Integrin Expression Regulates Th2 Effector Homing1 , 2008, The Journal of Immunology.

[12]  J. Mora,et al.  Homing imprinting and immunomodulation in the gut: role of dendritic cells and retinoids. , 2008, Inflammatory bowel diseases.

[13]  D. Ostanin,et al.  T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.

[14]  P. Mannon,et al.  The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.

[15]  C. Abraham,et al.  CD18 Is Required for Intestinal T Cell Responses at Multiple Immune Checkpoints1 , 2007, The Journal of Immunology.

[16]  G. Nickenig,et al.  Telmisartan inhibits β2-integrin MAC-1 expression in human T-lymphocytes , 2006 .

[17]  A. Hamann,et al.  Use of Labeled Lymphocytes to Analyze Trafficking In Vivo , 2006 .

[18]  R. D. Hatton,et al.  Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.

[19]  T. Mcclanahan,et al.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.

[20]  M. Claesson,et al.  Reactivity of naive CD4+CD25- T cells against gut microflora in healthy mice. , 2006, International immunology.

[21]  R. Förster,et al.  Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells , 2006, The Journal of experimental medicine.

[22]  A. Macpherson,et al.  Mesenteric lymph nodes at the center of immune anatomy , 2006, The Journal of experimental medicine.

[23]  D. Ostanin,et al.  Role of T-cell-associated lymphocyte function-associated antigen-1 in the pathogenesis of experimental colitis. , 2006, International immunology.

[24]  F. Cominelli,et al.  New Concepts in the Pathophysiology of Inflammatory Bowel Disease , 2005, Annals of Internal Medicine.

[25]  C. Abraham,et al.  CD18 Is Required for Optimal Development and Function of CD4+CD25+ T Regulatory Cells1 , 2005, The Journal of Immunology.

[26]  R. Alon,et al.  Immune cell migration in inflammation: present and future therapeutic targets , 2005, Nature Immunology.

[27]  S. Barnum,et al.  Critical Requirement of CD11b (Mac-1) on T Cells and Accessory Cells for Development of Experimental Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.

[28]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[29]  C. Elson,et al.  Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota , 2005, Immunological reviews.

[30]  F. Powrie,et al.  The role of mucosal T lymphocytes in regulating intestinal inflammation , 2005, Springer Seminars in Immunopathology.

[31]  C. Abraham,et al.  LFA-1 on CD4+ T Cells Is Required for Optimal Antigen-Dependent Activation In Vivo1 , 2004, The Journal of Immunology.

[32]  J. Rodgers,et al.  Deficiency of CD11b or CD11d Results in Reduced Staphylococcal Enterotoxin-Induced T Cell Response and T Cell Phenotypic Changes1 , 2004, The Journal of Immunology.

[33]  M. Claesson,et al.  Demonstration of strong enterobacterial reactivity of CD4+CD25– T cells from conventional and germ‐free mice which is counter‐regulated by CD4+CD25+ T cells , 2004, European journal of immunology.

[34]  Ulrich H. von Andrian,et al.  Homing and cellular traffic in lymph nodes , 2003, Nature Reviews Immunology.

[35]  T. Springer,et al.  Overlapping and Selective Roles of Endothelial Intercellular Adhesion Molecule-1 (ICAM-1) and ICAM-2 in Lymphocyte Trafficking 1 , 2003, The Journal of Immunology.

[36]  A. Mowat,et al.  Anatomical basis of tolerance and immunity to intestinal antigens , 2003, Nature Reviews Immunology.

[37]  C. Elson,et al.  Bacterial-Reactive T Regulatory Cells Inhibit Pathogenic Immune Responses to the Enteric Flora1 , 2002, The Journal of Immunology.

[38]  H. Smits,et al.  Intercellular Adhesion Molecule-1/LFA-1 Ligation Favors Human Th1 Development1 , 2002, The Journal of Immunology.

[39]  A. Zernecke,et al.  JAM-1 is a ligand of the β2 integrin LFA-1 involved in transendothelial migration of leukocytes , 2002, Nature Immunology.

[40]  F. Hug,et al.  The complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes: activation‐dependent up‐regulation and regulatory function , 2001, European journal of immunology.

[41]  Ke Xiong,et al.  Chemokines stimulate human T lymphocyte transendothelial migration to utilize VLA‐4 in addition to LFA‐1 , 2001, Journal of leukocyte biology.

[42]  P. A. Peterson,et al.  Costimulation via lymphocyte function-associated antigen 1 in the absence of CD28 ligation promotes anergy of naive CD4+ T cells. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  C. Abraham,et al.  Molecular mechanisms of IL-2 gene regulation following costimulation through LFA-1. , 2000, Journal of immunology.

[44]  N. Hogg,et al.  Lymphocyte Migration in Lymphocyte Function-associated Antigen (LFA)-1–deficient Mice , 1999, The Journal of experimental medicine.

[45]  C. Abraham,et al.  The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand. , 1999, Journal of immunology.

[46]  D. Mason,et al.  Control of immune pathology by regulatory T cells. , 1998, Current opinion in immunology.

[47]  J. Bluestone,et al.  LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. , 1998, Journal of immunology.

[48]  R. Steinman,et al.  Isolation of Dendritic Cells , 1998, Current protocols in immunology.

[49]  T. Mak,et al.  Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. , 1997, Immunity.

[50]  T. Mak,et al.  LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor , 1996, The Journal of experimental medicine.

[51]  F. Powrie,et al.  T cells in inflammatory bowel disease: protective and pathogenic roles. , 1995, Immunity.

[52]  T. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[53]  A. Beaudet,et al.  Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[54]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[55]  D. T. Bogue,et al.  Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. , 1991, Journal of immunology.

[56]  E. Lightfoot,et al.  Role of CD11/CD18 in adhesion and transendothelial migration of T cells. Analysis utilizing CD18-deficient T cell clones. , 1991, Journal of immunology.

[57]  C. Smith,et al.  Suppression of human lymphocyte chemotaxis and transendothelial migration by anti-LFA-1 antibody. , 1989, Journal of immunology.

[58]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[59]  G. Nickenig,et al.  Telmisartan inhibits beta2-integrin MAC-1 expression in human T-lymphocytes. , 2006, Journal of hypertension.

[60]  D. Ostanin,et al.  T cell-induced inflammation of the small and large intestine in immunodeficient mice. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[61]  U. V. Andrian,et al.  Adhesion and Communication Between Lymphocytes and Endothelial Cells , 2003 .

[62]  O. Perez,et al.  Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1 , 2003, Nature Immunology.